The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis
Y Du, J Li, F He, Y Lv, W Liu, P Wu, J Huang, S Wei… - PloS one, 2014 - journals.plos.org
Background The presence of antibodies against the M-type phospholipase A2 receptor
(PLA2R-AB) is considered to be a promising serological diagnostic biomarker of idiopathic …
(PLA2R-AB) is considered to be a promising serological diagnostic biomarker of idiopathic …
Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease
Q Wang, Z Dong, W Zhang, X Liu, Y Qu, S Duan… - Clinica Chimica …, 2020 - Elsevier
Aim Serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are highly accurate in
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …
Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 …
T Li, Q Wu, X Yang, Y Zhang, X Zhou, H Sheng… - Clinical …, 2021 - Elsevier
Background The renal biopsy is an accurate and reliable gold standard for membranous
nephropathy (MN) diagnosis. However, it is an invasive procedure involving the risk of …
nephropathy (MN) diagnosis. However, it is an invasive procedure involving the risk of …
[HTML][HTML] Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 …
EJ Escalante, AS Medrano, CC Cáceres… - Nefrología (English …, 2015 - Elsevier
In membranous nephropathy, the presence of antibodies against M-type phospholipase A2
receptor is considered highly specific for idiopathic forms. However, no specific association …
receptor is considered highly specific for idiopathic forms. However, no specific association …
PLA2R and membranous nephropathy: a 3 year prospective Australian study
PA Hill, JL McRae, KM Dwyer - Nephrology, 2016 - Wiley Online Library
Aim The phospholipase A2 receptor (PLA2R) is the major target antigen in idiopathic
membranous nephropathy (iMN). The aim of this prospective study was to determine the …
membranous nephropathy (iMN). The aim of this prospective study was to determine the …
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
O Ragy, V Rautemaa, A Smith, P Brenchley… - PLoS …, 2023 - journals.plos.org
Background Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology
practice has not changed dramatically, with most nephrologists still relying on a kidney …
practice has not changed dramatically, with most nephrologists still relying on a kidney …
Anti-phospholipase A2 receptor autoantibody: A new biomarker for primary membranous nephropathy
Q Zhu - Immunology, Endocrine & Metabolic Agents in …, 2016 - ingentaconnect.com
Primary membranous nephropathy (also known as idiopathic membranous nephropathy,
IMN) is an organ specific autoimmune kidney disease characterized by the development of …
IMN) is an organ specific autoimmune kidney disease characterized by the development of …
Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: a cross-sectional study
L Pang, AM Zhang, HX Li, JL Du, LL Jiao, N Duan… - Medicine, 2017 - journals.lww.com
M-type phospholipase A2 receptor (PLA2R) is the major target antigen in primary
membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of …
membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of …
[HTML][HTML] A comparison of chemiluminescent immunoassay and enzyme-linked immunosorbent assay for detecting phospholipase A2 receptor antibody in primary …
X Ma, R Wang, L Wei, P Liu, L Jing, J Wang… - Practical Laboratory …, 2024 - Elsevier
Objective The accurate detection of phospholipase A2 receptor (PLA2R) autoantibody is
crucial in the diagnosis and monitoring of primary membranous nephropathy (pMN). While …
crucial in the diagnosis and monitoring of primary membranous nephropathy (pMN). While …
Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
G Stefan, S Stancu, A Zugravu, O Popa, D Zubidat… - Renal …, 2022 - Taylor & Francis
Background The value of anti-phospholipase A2 receptor antibody (anti-PLA2R ab)
monitoring at 3 months after diagnosis in membranous nephropathy (MN) remains …
monitoring at 3 months after diagnosis in membranous nephropathy (MN) remains …